Q3297366 (Q3297366): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): Innovative companies serve highly regulated markets as developers and producers in the field of medical technology. The approval process and the market launch require the production of approval samples and a so-called zero series of — depending on the product — several hundred to thousand elements per year. This is where MedAssembly’s range of services starts. It offers a compliant manufacturing environment for miniaturised medical technology...) |
||||||||||||||
| Property / summary | |||||||||||||||
Innovative companies serve highly regulated markets as developers and producers in the field of medical technology. The approval process and the market launch require the production of approval samples and a so-called zero series of — depending on the product — several hundred to thousand elements per year. This is where MedAssembly’s range of services starts. It offers a compliant manufacturing environment for miniaturised medical technology systems and components, their standard-compliant organisation and knowledge of numerous relevant approval conditions. Through expert advice from the design phase as well as sample and zero series production during the approval and market launch phases, MedAssembly enables SMEs to translate new technical solutions into successful products that are much faster and risk-free and significantly reduce high investments in manufacturing capacities. (English) | |||||||||||||||
| Property / summary: Innovative companies serve highly regulated markets as developers and producers in the field of medical technology. The approval process and the market launch require the production of approval samples and a so-called zero series of — depending on the product — several hundred to thousand elements per year. This is where MedAssembly’s range of services starts. It offers a compliant manufacturing environment for miniaturised medical technology systems and components, their standard-compliant organisation and knowledge of numerous relevant approval conditions. Through expert advice from the design phase as well as sample and zero series production during the approval and market launch phases, MedAssembly enables SMEs to translate new technical solutions into successful products that are much faster and risk-free and significantly reduce high investments in manufacturing capacities. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Innovative companies serve highly regulated markets as developers and producers in the field of medical technology. The approval process and the market launch require the production of approval samples and a so-called zero series of — depending on the product — several hundred to thousand elements per year. This is where MedAssembly’s range of services starts. It offers a compliant manufacturing environment for miniaturised medical technology systems and components, their standard-compliant organisation and knowledge of numerous relevant approval conditions. Through expert advice from the design phase as well as sample and zero series production during the approval and market launch phases, MedAssembly enables SMEs to translate new technical solutions into successful products that are much faster and risk-free and significantly reduce high investments in manufacturing capacities. (English) / qualifier | |||||||||||||||
point in time: 24 October 2021
| |||||||||||||||
Revision as of 16:06, 24 October 2021
Project Q3297366 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3297366 in Germany |
Statements
730,000.0 Euro
0 references
1,460,000.0 Euro
0 references
50.0 percent
0 references
13 December 2016
0 references
31 December 2021
0 references
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.
0 references
Innovative Unternehmen bedienen als Entwickler und Produzenten im Bereich Medizintechnik stark regulierte Märkte. Das Zulassungs-Prozedere und die Markteinführung benötigen die Fertigung von Zulassungsmustern und eine sogenannten Nullserie von - je nach Produkt - einigen hundert bis tausend Elementen pro Jahr. An dieser Stelle setzt das Dienstleistungsangebot von MedAssembly an. Es bietet eine konforme Fertigungsumgebung für miniaturisierte medizintechnische Systeme und Komponenten, deren normgerechte Organisation und das Wissen über zahlreiche relevante Zulassungsbedingungen. Durch fachgerechte Beratung ab der Konzeptionsphase sowie Muster- und Nullserienfertigung während der Zulassungs- und Markteinführungsphase können KMU durch MedAssembly wesentlich schneller und risikofreier neue technische Lösungen in erfolgreiche Produkte umsetzen und hohe Investitionen für die Fertigungskapazitäten stark reduzieren. (German)
0 references
Innovative companies serve highly regulated markets as developers and producers in the field of medical technology. The approval process and the market launch require the production of approval samples and a so-called zero series of — depending on the product — several hundred to thousand elements per year. This is where MedAssembly’s range of services starts. It offers a compliant manufacturing environment for miniaturised medical technology systems and components, their standard-compliant organisation and knowledge of numerous relevant approval conditions. Through expert advice from the design phase as well as sample and zero series production during the approval and market launch phases, MedAssembly enables SMEs to translate new technical solutions into successful products that are much faster and risk-free and significantly reduce high investments in manufacturing capacities. (English)
24 October 2021
0 references
Villingen-Schwenningen
0 references
Identifiers
DE_TEMPORARY_145
0 references